Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
Protein Kinase Targets
Protein Kinase Targets
/
c-Met/HGFR
c-Met/HGFR
c-Met/HGFR
Products (27)
Zurletrectinib
CAS No.:
2403703-30-8
Capmatinib
CAS No.:
1029712-80-8
Merestinib
CAS No.:
1206799-15-6
Mk-2461
CAS No.:
917879-39-1
Bms-777607
CAS No.:
1025720-94-8
Bms-754807
CAS No.:
1001350-96-4
Capmatinib Hydrochloride
CAS No.:
1865733-40-9
Savolitinib
CAS No.:
1313725-88-0
Glesatinib
CAS No.:
936694-12-1
Pf-04217903
CAS No.:
956905-27-4
Tivantinib
CAS No.:
905854-02-6
Dalmelitinib
CAS No.:
1637658-98-0
Golvatinib
CAS No.:
928037-13-2
Mk-8033
CAS No.:
1001917-37-8
Vebreltinib
CAS No.:
1440964-89-5
Mifanertinib
CAS No.:
1639014-72-4
N~1~-(4-Fluorophenyl)-N'~1~-(4-((2-((2-(morpholin-4-yl)ethyl)carbamoyl)-1H-pyrrolo(2,3-b)pyridin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide
CAS No.:
1021950-26-4
TAM&Met-IN-1
CAS No.:
2412356-57-9
Canlitinib
CAS No.:
2222730-78-9
Terevalefim
CAS No.:
1070881-42-3
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact